David R. Stevens - 13 Oct 2021 Form 4 Insider Report for Ampio Pharmaceuticals, Inc.

Role
Director
Signature
/s/ Daniel Stokely, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
13 Oct 2021
Net transactions value
$0
Form type
4
Filing time
15 Oct 2021, 14:43:06 UTC
Next filing
03 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPE Stock Option (Right to Buy) Award $0 +120,000 $0.000000 120,000 13 Oct 2021 Common Stock 120,000 $1.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 50% on the grant date and 50% on March 31, 2022.